⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NTLA News
Intellia Therapeutics, Inc
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
NTLA
Form 8-K
sec.gov
NTLA
Intellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates
globenewswire.com
NTLA
Intellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates
globenewswire.com
NTLA
Intellia Therapeutics to Hold Conference Call on August 6 to Discuss Second Quarter 2026 Financial Results and Business Updates
globenewswire.com
NTLA
Mana.bio Announces the Appointment of Laura Sepp-Lorenzino to its Scientific Advisory Board
prnewswire.com
NTLA
VRTX
ALNY
MRK
TGTX
LXEO
Les sept microsatellites d’observation de la Terre GRUS-3 d’Axelspace ont été lancés avec succès et les premiers signaux ont été reçus
businesswire.com
NXPI
GOOG
AMZN
MSFT
NVDA
INTC
AMD
META
TSLA
JBL
HON
LMT
BA
GD
RTX
IBM
QCOM
MU
ADI
TXN
VRTX
REGN
GILD
BMY
MRK
PFE
JNJ
ABBV
AMGN
BIIB
CRSP
EDIT
NTLA
ILMN
ROKU
NFLX
DIS
CMCSA
T
VZ
TMUS
CRM
ADBE
PYPL
COIN
MARA
RIOT
PLTR
SNOW
DDOG
ZS
CRWD
PANW
FTNT
NOW
CVS
UNH
EL
LULU
NKE
SBUX
MCD
YUM
SIRI
UBER
LYFT
EXAS
ALGN
BABA
JD
BIDU
NTES
PDD
FOXA
NWSA
WMT
COST
HD
LOW
PG
CL
KHC
PEP
KO
MDT
SYK
DHR
ISRG
ABT
TMO
XOM
CVX
SHEL
COP
EOG
OXY
APA
DVN
HAL
SLB
BKR
SPG
PLD
AMT
EQIX
CCI
SBAC
AMAT
LRCX
ASML
KLAC
WDC
SE
MELI
SHOP
ETSY
EBAY
EXPE
BKNG
MAR
HLT
IHG
WYNN
LVS
MGM
CCL
RCL
NCLH
AAL
UAL
DAL
LUV
JBLU
ALK
AVGO
MRVL
MCHP
ON
INFY
NIO
XPEV
LI
BYD
SAIC
BYDDF
BILI
IQ
VIPS
GOOGL
SPCE
RKLB
ASTS
Gene Editing Market to Reach US$30.5 Billion by 2033 as Precision Medicine and CRISPR Innovation Accelerate Growth - Persistence Market Research
prnewswire.com
CRSP
NTLA
TMO
SANG
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
NTLA
Gene Editing Therapeutics: Transforming Biopharmaceuticals with 12.5% CAGR Growth Forecast
globenewswire.com
CRSP
NTLA
EDIT
BEAM
SANG
CELC
CRBU
PRME